trial

A Pilot Trial of Acute N-Acetylcysteine Effects on Working Memory and Other Cognitive Functions in Schizophrenia

NCTId NCT01232790
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 28 (actual)
Sponsored by Yale University
Primary completion 2011-11
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
28 (actual)
Study type
Interventional
Allocation
Randomized
Model
Crossover
Masking
Double
Start
2010-02
Primary completion
2011-11
Eligibility
ALL · 18 Years · 60 Years

Interventions & indications

Drugs
N-acetylcysteine

Sponsors

Yale UniversityLead Sponsor
National Alliance for Research on Schizophrenia and DepressionCollaborator

Investigators

1
Cenk Tek, MDPrincipal Investigator

Sites

1 total
New Haven, United States

Facts & assertions

4 sourced
Enrollment
28
Phase
NA
Primary Completion Date
2011-11
Status
COMPLETED
relationships
The graph out of here
drug
N-acetylcysteine
drug
lead_sponsor
Yale University
company
collaborator
National Alliance for Research on Schizophrenia and Depression
company
indication
Schizophrenia
indication
Schizophrenia
indication
investigator
Cenk Tek, MD
person